We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$438M
AUM Growth
+$25.1M
Cap. Flow
+$13.6M
Cap. Flow %
3.1%
Top 10 Hldgs %
21.07%
Holding
312
New
80
Increased
50
Reduced
26
Closed
102

Top Buys

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$8.29M
2
IDCC icon
InterDigital
IDCC
+$4.45M
3
CTSH icon
Cognizant
CTSH
+$4.02M
4
GL icon
Globe Life
GL
+$3.82M
5
G icon
Genpact
G
+$3.8M

Sector Composition

Rank Sector Weight
1 Healthcare 22.59%
2 Technology 17.67%
3 Materials 16.79%
4 Financials 11.81%
5 Consumer Staples 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFSC icon
76
Enterprise Financial Services Corp
EFSC
$2.42B
$2.31M 0.53%
+42,000
New +$2.19M
PCTY icon
77
Paylocity
PCTY
$7.91B
$2.28M 0.52%
+12,600
New +$2.37M
JAZZ icon
78
Jazz Pharmaceuticals
JAZZ
$16.4B
$2.23M 0.51%
+21,000
New +$2.28M
ZION icon
79
Zions Bancorporation
ZION
$10.5B
$2.18M 0.5%
42,000
+10,500
+33% +$493K
CVS icon
80
CVS Health
CVS
$126B
$2.17M 0.5%
+31,500
New +$2.07M
PAAS icon
81
Pan American Silver
PAAS
$20.3B
$2.17M 0.5%
76,500
-30,500
-29% -$789K
PAHC icon
82
Phibro Animal Health
PAHC
$1.46B
$2.15M 0.49%
84,000
-42,000
-33% -$916K
ALNY icon
83
Alnylam Pharmaceuticals
ALNY
$30.6B
$2.05M 0.47%
6,300
-2,100
-25% -$581K
RIVN icon
84
Rivian
RIVN
$22.5B
$2.02M 0.46%
147,000
-21,000
-13% -$285K
KLG
85
DELISTED
WK Kellogg Co
KLG
$2.01M 0.46%
126,000
ALSN icon
86
Allison Transmission
ALSN
$9.8B
$1.99M 0.46%
+21,000
New +$2.03M
ASAN icon
87
Asana
ASAN
$2.05B
$1.98M 0.45%
+147,000
New +$2.3M
CAKE icon
88
Cheesecake Factory
CAKE
$5.23B
$1.97M 0.45%
31,500
+4,200
+15% +$223K
WGS icon
89
GeneDx Holdings
WGS
$2.08B
$1.94M 0.44%
21,000
-10,500
-33% -$824K
SBUX icon
90
Starbucks
SBUX
$121B
$1.92M 0.44%
+21,000
New +$1.82M
INSP icon
91
Inspire Medical Systems
INSP
$1.73B
$1.91M 0.44%
+14,700
New +$2.13M
BCRX icon
92
BioCryst Pharmaceuticals
BCRX
$2.31B
$1.88M 0.43%
210,000
-105,000
-33% -$978K
FFIV icon
93
F5
FFIV
$23.4B
$1.85M 0.42%
6,300
+2,100
+50% +$580K
PSA icon
94
Public Storage
PSA
$61.1B
$1.85M 0.42%
+6,300
New +$1.87M
HL icon
95
Hecla Mining
HL
$11.1B
$1.83M 0.42%
306,000
+51,000
+20% +$281K
SPRY icon
96
ARS Pharmaceuticals
SPRY
$532M
$1.83M 0.42%
+105,000
New +$1.52M
IONQ icon
97
IonQ
IONQ
$14.9B
$1.8M 0.41%
42,000
-63,000
-60% -$2.11M
CHWY icon
98
Chewy
CHWY
$9.84B
$1.79M 0.41%
42,000
-42,000
-50% -$1.67M
CCL icon
99
Carnival Corporation Ltd
CCL
$40.6B
$1.77M 0.4%
+63,000
New +$1.35M
PTGX icon
100
Protagonist Therapeutics
PTGX
$8.83B
$1.74M 0.4%
31,500
-21,000
-40% -$1.01M

Similar funds

Hussman Strategic Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Hussman Strategic Advisors held 312 positions worth $438M, up 6.1% from $413M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Hussman Strategic Advisors deployed $13.6M of net new capital in Q2 2025, opening 80 new positions and adding to 50 existing holdings. Its largest new stake was InterDigital: 21,000 shares worth $4.71M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was AngloGold Ashanti, an estimated $4.39M trimmed.

  • Hussman Strategic Advisors's largest Q2 2025 buy was InterDigital: 21,000 shares worth $4.71M.
  • Hussman Strategic Advisors added most to Agnico Eagle Mines in Q2 2025, an estimated $8.29M increase.
  • Hussman Strategic Advisors's biggest Q2 2025 reduction was AngloGold Ashanti, cutting an estimated $4.39M.
  • Hussman Strategic Advisors fully exited Alphabet (Google) Class C in Q2 2025, selling an estimated $4.92M.
  • Hussman Strategic Advisors's ten largest holdings make up 21% of its $438M portfolio in Q2 2025.
  • Hussman Strategic Advisors opened 80 new positions and closed 102 in Q2 2025.
  • Hussman Strategic Advisors's portfolio value rose 6.1% quarter-over-quarter to $438M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.